German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
Biosimilars are biological drugs that are highly similar to another biological medicine, the so-called originator. The biosimilars have no clinically meaningful differences to
Manufacturers of drugs or medical devices can apply for a consultation meeting with the G-BA before submitting a dossier. This consultation offers
On 6 December 2021, Prof. Dr. Karl Lauterbach was announced as the new German health minister. This might mean quite a lot
The new government in Germany is formed as a coalition of the three parties, SDP, FDP and the Green Party. At the
Currently, free pricing of products with a new chemical entity (NCE) applies in the first year. This means, at the time of